# clm_45C96BE1D685

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: research_and_development  
value: 3,036,600,000 United States dollar  
valid_from: 2019-12-31  
valid_to: 2020-12-31  
published: 2020-02-07  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_55C14CEED321  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals research and development: 3,036,600,000 United States dollar", as of 2019-12-31 (until 2020-12-31). Claim clm_45C96BE1D685, https://asof.is/claim/clm_45C96BE1D685, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000153217620000008/0001532176-20-000008-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-K FY2019, filed 2020-02-07  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000153217620000008/0001532176-20-000008-index.htm (primary, SEC EDGAR 10-K FY2019, published 2020-02-07)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | research_and_development | 2,186,100,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_45C96BE1D685](/claim/clm_45C96BE1D685.md) | [clm_266453DBFA15](/claim/clm_266453DBFA15.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.